Susanna Hilda Hutajulu1, Dewi Kartikawati Paramita2, Joyo Santoso3, Muhammad Ivan Aulia Sani4, Aghnia Amalia4, Gatri Wulandari4, Ahmad Ghozali5, Johan Kurnianda1. 1. Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada/Dr Sardjito Hospital, Yogyakarta, Indonesia. 2. Department of Histology and Cell Biology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia. 3. Department of Internal Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada/Dr Sardjito Hospital, Yogyakarta, Indonesia. 4. Study Program of Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia. 5. Department of Anatomical Pathology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada/Dr Sardjito Hospital, Yogyakarta, Indonesia.
Abstract
BACKGROUND: Vascular endothelial growth factor-A (VEGF-A) has been observed as the predominant angiogenic factor in colorectal cancer (CRC) and the assessment of microvessel density (MVD) has been used to quantify tumor neoangiogenesis. This study aimed to determine clinicopathological and prognostic significance of both angiogenic markers in the local CRC patients. METHODS: We analyzed tissue samples obtained from 81 cases with CRC. VEGF-A expression and MVD counts were immunohistochemically detected using anti VEGF-A and CD31. The assessments of both markers were classified as low and high. Correlation between VEGF-A expression and MVD value and clinicopathological characteristics were examined using Chi-square test. The overall survival (OS) was plotted using the Kaplan-Meier method. RESULTS: High VEGF-A expression was found more frequently in the rectal location (P=0.042) and T4 tumors (P=0.041) compared to their counterparts. Older patients tended to show a higher MVD value compared to younger cases (P=0.062). In addition, survival analysis showed that males had a worse OS compared to females (P=0.029), and VEGF-A expression and MVD count did not correlate with patients' survival. CONCLUSIONS: There were significant differences of VEGF-A expression according to tumor location and T invasion. Sex, but not angiogenic markers, had an influence on the survival of CRC patients.
BACKGROUND: Vascular endothelial growth factor-A (VEGF-A) has been observed as the predominant angiogenic factor in colorectal cancer (CRC) and the assessment of microvessel density (MVD) has been used to quantify tumor neoangiogenesis. This study aimed to determine clinicopathological and prognostic significance of both angiogenic markers in the local CRC patients. METHODS: We analyzed tissue samples obtained from 81 cases with CRC. VEGF-A expression and MVD counts were immunohistochemically detected using anti VEGF-A and CD31. The assessments of both markers were classified as low and high. Correlation between VEGF-A expression and MVD value and clinicopathological characteristics were examined using Chi-square test. The overall survival (OS) was plotted using the Kaplan-Meier method. RESULTS: High VEGF-A expression was found more frequently in the rectal location (P=0.042) and T4 tumors (P=0.041) compared to their counterparts. Older patients tended to show a higher MVD value compared to younger cases (P=0.062). In addition, survival analysis showed that males had a worse OS compared to females (P=0.029), and VEGF-A expression and MVD count did not correlate with patients' survival. CONCLUSIONS: There were significant differences of VEGF-A expression according to tumor location and T invasion. Sex, but not angiogenic markers, had an influence on the survival of CRC patients.
Entities:
Keywords:
Vascular endothelial growth factor-A (VEGF-A); colorectal cancer (CRC); microvessel density (MVD); tumor invasion; tumor location
Authors: W A Bleeker; V M Hayes; A Karrenbeld; R M Hofstra; J Hermans; C C Buys; J T Plukker Journal: Am J Gastroenterol Date: 2000-10 Impact factor: 10.864
Authors: Vickie Hanrahan; Margaret J Currie; Sarah P Gunningham; Helen R Morrin; Prudence A E Scott; Bridget A Robinson; Stephen B Fox Journal: J Pathol Date: 2003-06 Impact factor: 7.996
Authors: Jeff D White; Peter W Hewett; Dennis Kosuge; Thomas McCulloch; Berndt C Enholm; James Carmichael; J Clifford Murray Journal: Cancer Res Date: 2002-03-15 Impact factor: 12.701
Authors: G Des Guetz; B Uzzan; P Nicolas; M Cucherat; J-F Morere; R Benamouzig; J-L Breau; G-Y Perret Journal: Br J Cancer Date: 2006-06-19 Impact factor: 7.640
Authors: Farahlina Baba; Aidy Irman Yajid; Siti Norasikin Mohd Nafi; Siti Azrin Ab Hamid; Wan Nor Asyikeen Wan Adnan; Nur Asyilla Che Jalil Journal: Asian Pac J Cancer Prev Date: 2022-03-01